PCR in diagnosis of invasive Aspergillosis: A Meta-Analysis of diagnostic performance

Journal of Clinical Microbiology

Volumn 52, Issue 10, 2014, Pages 3731-3742

  Arvanitis, Marios ^a,b   Ziakas, Panayiotis D ^a,b   Zacharioudakis, Ioannis M ^a,b   Zervou, Fainareti N ^a,b   Caliendo, Angela M ^a,b   Mylonakis, Eleftherios ^a,b  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASPERGILLUS; BLOOD; CLINICAL TRIAL (TOPIC); CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HIGH RISK PATIENT; HUMAN; INVASIVE ASPERGILLOSIS; META ANALYSIS; POLYMERASE CHAIN REACTION; QUALITY CONTROL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; STANDARD; ADULT; CHILD; COMPLICATION; EVALUATION STUDY; GENETICS; HEMATOLOGIC DISEASE; INVASIVE PULMONARY ASPERGILLOSIS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR DIAGNOSIS; PRESCHOOL CHILD; PROCEDURES;

ADULT; ASPERGILLUS; BLOOD; CHILD; CHILD, PRESCHOOL; HEMATOLOGIC NEOPLASMS; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84907168711     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01365-14     Document Type: Article

References (70)

1. Ramos ER, Jiang Y, Hachem R, Kassis C, Kontoyiannis DP, Raad I. 2011. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: The role of novel antimold azoles. Oncologist 16:1049-1060. http://dx.doi.org/10.1634/theoncologist.2010-0290.
2. Omer AK, Ziakas PD, Anagnostou T, Coughlin E, Kourkoumpetis T, McAfee SL, Dey BR, Attar E, Chen YB, Spitzer TR, Mylonakis E, Ballen KK. 2013. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: A single center experience. Biol. Blood Marrow Transplant. 19:1190-1196. http://dx.doi.org/10.1016/j.bbmt.2013.05.018.
3. Ziakas PD, Kourbeti IS, Voulgarelis M, Mylonakis E. 2010. Effectiveness of systemic antifungal prophylaxis in patients with neutropenia after chemotherapy: A meta-analysis of randomized controlled trials. Clin. Ther. 32:2316-2336. http://dx.doi.org/10.1016/j.clinthera.2011.01.009.
4. Ziakas PD, Kourbeti IS, Mylonakis E. 2014. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: A metaanalysis. Clin. Ther. 36:292-306 e291. http://dx.doi.org/10.1016/j.clinthera.2013.11.010.
5. Morrissey CO, Chen SC, Sorrell TC, Milliken S, Bardy PG, Bradstock KF, Szer J, Halliday CL, Gilroy NM, Moore J, Schwarer AP, Guy S, Bajel A, Tramontana AR, Spelman T, Slavin MA, Australasian Leukaemia Lymphoma Group, Australia and New Zealand Mycology Interest Group. 2013. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: A randomised controlled trial. Lancet Infect. Dis. 13:519-528. http://dx.doi.org/10.1016/S1473-3099(13)70076-8.
6. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancerr, Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin. Infect. Dis. 34:7-14. http://dx.doi.org/10.1086/323335.
7. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Munoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821. http://dx.doi.org/10.1086/588660.
8. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. 2009. Use of PCR for diagnosis of invasive aspergillosis: systematic review and metaanalysis. Lancet Infect. Dis. 9:89-96. http://dx.doi.org/10.1016/S1473-3099(09)70019-2.
9. Arvanitis M, Anagnostou T, Fuchs BB, Caliendo AM, Mylonakis E. 2014. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin. Microbiol. Rev. 27:490-526. http://dx.doi.org/10.1128/CMR.00091-13.
10. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. 2009. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 339:b2535. http://dx.doi.org/10.1136/bmj.b2535.
11. Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Bossuyt PM, Vandenbroucke-Grauls CM. 2008. Galactomannan detection for invasive aspergillosis in immunocompromized [sic] patients. Cochrane Database Syst. Rev. http://dx.doi.org/10.1002/14651858.CD007394.
12. White PL, Bretagne S, Klingspor L, Melchers WJ, McCulloch E, Schulz B, Finnstrom N, Mengoli C, Barnes RA, Donnelly JP, Loeffler J, European Aspergillus PCR Initiative. 2010. Aspergillus PCR: one step closer to standardization. J. Clin. Microbiol. 48:1231-1240. http://dx.doi.org/10.1128/JCM.01767-09.
13. White PL, Mengoli C, Bretagne S, Cuenca-Estrella M, Finnstrom N, Klingspor L, Melchers WJ, McCulloch E, Barnes RA, Donnelly JP, Loeffler J, European Aspergillus PCR Initiative. 2011. Evaluation of Aspergillus PCR protocols for testing serum specimens. J. Clin. Microbiol. 49:3842-3848. http://dx.doi.org/10.1128/JCM.05316-11.
14. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, QUADAS-2 Group. 2011. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 155:529-536. http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00009.
15. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. 2005. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J. Clin. Epidemiol. 58:982-990. http://dx.doi.org/10.1016/j.jclinepi.2005.02.022.
16. Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P, Mant D, McManus RJ, Holder R, Deeks J, Fletcher K, Qume M, Sohanpal S, Sanders S, Hobbs FD. 2009. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol. Assess. 13:1-207, iii. http://dx.doi.org/10.3310/hta13320.
17. Harbord RM, Whiting P, Sterne JA, Egger M, Deeks JJ, Shang A, Bachmann LM. 2008. An empirical comparison of methods for metaanalysis of diagnostic accuracy showed hierarchical models are necessary. J. Clin. Epidemiol. 61:1095-1103. http://dx.doi.org/10.1016/j.jclinepi.2007.09.013.
18. Grimes DA, Schulz KF. 2005. Refining clinical diagnosis with likelihood ratios. Lancet 365:1500-1505. http://dx.doi.org/10.1016/S0140-6736(05) 66422-7.
19. Deeks JJ, Macaskill P, Irwig L. 2005. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J. Clin. Epidemiol. 58:882-893. http://dx.doi.org/10.1016/j.jclinepi.2005.01.016.
20. Prodromou ML, Ziakas PD, Poulou LS, Karsaliakos P, Thanos L, Mylonakis E. 2014. FDG PET is a robust tool for the diagnosis of spondylodiscitis: A meta-analysis of diagnostic data. Clin. Nucl. Med. 39:330-335. http://dx.doi.org/10.1097/RLU.0000000000000336.
21. Ziakas PD, Poulou LS, Voulgarelis M, Thanos L. 2012. The Gordian knot of interim 18-fluorodeoxyglucose positron emission tomography for Hodgkin lymphoma: A meta-analysis and commentary on published studies. Leuk. Lymphoma 53:2166-2174. http://dx.doi.org/10.3109/10428194.2012.685730.
22. Dwamena BA. 2009. Evidence-based radiology: step 3-diagnostic systematic review and meta-analysis (critical appraisal). Semin. Roentgenol. 44:170-179. http://dx.doi.org/10.1053/j.ro.2009.03.007.
23. Wallace BC, Schmid CH, Lau J, Trikalinos TA. 2009. Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med. Res. Methodol. 9:80. http://dx.doi.org/10.1186/1471-2288-9-80.
24. Raad I, Hanna H, Sumoza D, Albitar M. 2002. Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients. Cancer 94:1032-1036. http://dx.doi.org/10.1002/cncr.10349.
25. Buchheidt D, Baust C, Skladny H, Ritter J, Suedhoff T, Baldus M, Seifarth W, Leib-Moesch C, Hehlmann R. 2001. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin. Infect. Dis. 33:428-435. http://dx.doi.org/10.1086/321887.
26. Halliday C, Hoile R, Sorrell T, James G, Yadav S, Shaw P, Bleakley M, Bradstock K, Chen S. 2006. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Br. J. Haematol. 132:478-486. http://dx.doi.org/10.1111/j.1365-2141.2005.05887.x.
27. Badiee P, Kordbacheh P, Alborzi A, Ramzi M, Shakiba E. 2008. Molecular detection of invasive aspergillosis in hematologic malignancies. Infection 36:580-584. http://dx.doi.org/10.1007/s15010-008-7385-8.
28. Hummel M, Spiess B, Cornely OA, Dittmer M, Morz H, Buchheidt D. 2010. Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial. Eur. J. Haematol. 85:164-169. http://dx.doi.org/10.1111/j.1600-0609.2010.01452.x.
29. White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. 2006. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin. Infect. Dis. 42:479-486. http://dx.doi.org/10.1086/499949.
30. Cesaro S, Stenghele C, Calore E, Franchin E, Cerbaro I, Cusinato R, Tridello G, Manganelli R, Carli M, Palu G. 2008. Assessment of the LightCycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases. Mycoses 51:497-504. http://dx.doi.org/10.1111/j.1439-0507.2008.01512.x.
31. Ramírez M, Castro C, Palomares JC, Torres MJ, Aller AI, Ruiz M, Aznar J, Martin-Mazuelos E. 2009. Molecular detection and identification of Aspergillus spp. from clinical samples using real-time PCR. Mycoses 52:129-134. http://dx.doi.org/10.1111/j.1439-0507.2008.01548.x
32. Jordanides NE, Allan EK, McLintock LA, Copland M, Devaney M, Stewart K, Parker AN, Johnson PR, Holyoake TL, Jones BL. 2005. A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients. Bone Marrow Transplant. 35:389-395. http://dx.doi.org/10.1038/sj.bmt.1704768.
33. Pryce TM, Kay ID, Palladino S, Heath CH. 2003. Real-time automated polymerase chain reaction (PCR) to detect Candida albicans and Aspergillus fumigatus DNA in whole blood from high-risk patients. Diagn. Microbiol. Infect. Dis. 47:487-496. http://dx.doi.org/10.1016/S0732-8893 (03)00139-1.
34. White PL, Archer AE, Barnes RA. 2005. Comparison of non-culturebased methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections. J. Clin. Microbiol. 43:2181-2187. http://dx.doi.org/10.1128/JCM.43.5.2181-2187.2005.
35. Scotter JM, Campbell P, Anderson TP, Murdoch DR, Chambers ST, Patton WN. 2005. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis. Pathology 37:246-253. http://dx.doi.org/10.1080/00313020500099148.
36. Ferns RB, Fletcher H, Bradley S, Mackinnon S, Hunt C, Tedder RS. 2002. The prospective evaluation of a nested polymerase chain reaction assay for the early detection of Aspergillus infection in patients with leukaemia or undergoing allograft treatment. Br. J. Haematol. 119:720-725. http://dx.doi.org/10.1046/j.1365-2141.2002.03862.x.
37. Barnes RA, White PL, Bygrave C, Evans N, Healy B, Kell J. 2009. Clinical impact of enhanced diagnosis of invasive fungal disease in highrisk haematology and stem cell transplant patients. J. Clin. Pathol. 62:64-69. http://dx.doi.org/10.1136/jcp.2008.058354.
38. Florent M, Katsahian S, Vekhoff A, Levy V, Rio B, Marie JP, Bouvet A, Cornet M. 2006. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J. Infect. Dis. 193:741-747. http://dx.doi.org/10.1086/500466.
39. Costa C, Costa JM, Desterke C, Botterel F, Cordonnier C, Bretagne S. 2002. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 40: 2224-2227. http://dx.doi.org/10.1128/JCM.40.6.2224-2227.2002.
40. Millon L, Piarroux R, Deconinck E, Bulabois CE, Grenouillet F, Rohrlich P, Costa JM, Bretagne S. 2005. Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis. J. Clin. Microbiol. 43:5097-5101. http://dx.doi.org/10.1128/JCM.43.10.5097-5101.2005.
41. Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, Chiba S, Motokura T, Hirai H, Ogawa S. 2004. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (13)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J. Clin. Microbiol. 42:2733-2741. http://dx.doi.org/10.1128/JCM.42.6.2733-2741.2004.
42. Botterel F, Farrugia C, Ichai P, Costa JM, Saliba F, Bretagne S. 2008. Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients. Transpl. Infect. Dis. 10:333-338. http://dx.doi.org/10.1111/j.1399-3062.2008.00323.x.
43. Suarez F, Lortholary O, Buland S, Rubio MT, Ghez D, Mahe V, Quesne G, Poiree S, Buzyn A, Varet B, Berche P, Bougnoux ME. 2008. Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in highrisk adult patients under hematologic surveillance. J. Clin. Microbiol. 46: 3772-3777. http://dx.doi.org/10.1128/JCM.01086-08.
44. Schwarzinger M, Sagaon-Teyssier L, Cabaret O, Bretagne S, Cordonnier C, Investigators P. 2013. Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: A multistate model. PLoS One 8(6):e65776. http://dx.doi.org/10.1371/journal.pone.0065776.
45. Pham AS, Tarrand JJ, May GS, Lee MS, Kontoyiannis DP, Han XY. 2003. Diagnosis of invasive mold infection by real-time quantitative PCR. Am. J. Clin. Pathol. 119:38-44. http://dx.doi.org/10.1309/RQ05PP9NEG6DADXR
46. El-Mahallawy HA, Shaker HH, Ali Helmy H, Mostafa T, Razak Abo-Sedah A. 2006. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients. Med. Mycol. 44:733-739. http://dx.doi.org/10.1080/13693780600939955.
47. Badiee P, Alborzi A. 2010. Detection of Aspergillus species in bone marrow transplant patients. J. Infect. Dev. Ctries. 4:511-516. http://dx.doi.org/10.3855/jidc.807.
48. Springer J, Loeffler J, Heinz W, Schlossnagel H, Lehmann M, Morton O, Rogers TR, Schmitt C, Frosch M, Einsele H, Kurzai O. 2011. Pathogen-specific DNA enrichment does not increase sensitivity of PCR for diagnosis of invasive aspergillosis in neutropenic patients. J. Clin. Microbiol. 49:1267-1273. http://dx.doi.org/10.1128/JCM.01679-10.
49. Bernal-Martínez L, Gago S, Buitrago MJ, Gomez-Lopez A, Rodriguez-Tudela JL, Cuenca-Estrella M. 2011. Analysis of performance of a PCRbased assay to detect DNA of Aspergillus fumigatus in whole blood and serum: A comparative study with clinical samples. J. Clin. Microbiol. 49: 3596-3599. http://dx.doi.org/10.1128/JCM.00647-11.
50. Springer J, Schlossnagel H, Heinz W, Doedt T, Soeller R, Einsele H, Loeffler J. 2012. A novel extraction method combining plasma with a whole-blood fraction shows excellent sensitivity and reproducibility for patients at high risk for invasive aspergillosis. J. Clin. Microbiol. 50:2585-2591. http://dx.doi.org/10.1128/JCM.00523-12.
51. Springer J, Morton CO, Perry M, Heinz WJ, Paholcsek M, Alzheimer M, Rogers TR, Barnes RA, Einsele H, Loeffler J, White PL. 2013. Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients. J. Clin. Microbiol. 51:1445-1450. http://dx.doi.org/10.1128/JCM.03322-12.
52. Rogers TR, Morton CO, Springer J, Conneally E, Heinz W, Kenny C, Frost S, Einsele H, Loeffler J. 2013. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies. Br. J. Haematol. 161:517-524. http://dx.doi.org/10.1111/bjh.12285.
53. Sugawara Y, Nakase K, Nakamura A, Ohishi K, Sugimoto Y, Fujieda A, Monma F, Suzuki K, Masuya M, Matsushima Y, Wada H, Nobori T, Katayama N. 2013. Clinical utility of a panfungal polymerase chain reaction assay for invasive fungal diseases in patients with haematologic disorders. Eur. J. Haematol. 90:331-339. http://dx.doi.org/10.1111/ejh.12078.
54. Li Y, Gao L, Ding Y, Xu Y, Zhou M, Huang W, Jing Y, Li H, Wang L, Yu L. 2013. Establishment and application of real-time quantitative PCR for diagnosing invasive aspergillosis via the blood in hematological patients: Targeting a specific sequence of Aspergillus 28S-ITS2. BMC Infect. Dis. 13:255. http://dx.doi.org/10.1186/1471-2334-13-255.
55. White PL, Parr C, Thornton C, Barnes RA. 2013. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 51:1510-1516. http://dx.doi.org/10.1128/JCM.03189-12.
56. Nabili M, Shokohi T, Janbabaie G, Hashemi-Soteh MB, Ali-Moghaddam K, Aghili SR. 2013. Detection of invasive aspergillosis in bone marrow transplant recipients using real-time PCR. J. Glob. Infect. Dis. 5:68-75. http://dx.doi.org/10.4103/0974-777X.112296.
57. Lopes da Silva R, Ribeiro P, Abreu N, Ferreira T, Fernandes T, Monteiro A, Costa F, Caldas J, Silva M, Carande L, Ferreira G, Conduto A, Cruz E, Sousa MH, Rodrigues AS, Costa I, Veiga J, de Sousa AB. 2010. Early diagnosis of invasive aspergillosis in neutropenic patients. Comparison between serum galactomannan and polymerase chain reaction. Clin. Med. Insights Oncol. 4:81-88. http://dx.doi.org/10.4137/CMO.S5228.
58. Badiee P, Alborzi A, Karimi M, Pourabbas B, Haddadi P, Mardaneh J, Moieni M. 2012. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients. J. Infect. Dev. Ctries. 6:352-357. http://dx.doi.org/10.3855/jidc.2110.
59. Millon L, Grenouillet F, Legrand F, Loewert S, Bellanger AP, Gbaguidi-Haore H, Scherer E, Henon T, Rohrlich P, Deconinck E. 2011. Ribosomal and mitochondrial DNA target for real-time PCR diagnosis of invasive aspergillosis. J. Clin. Microbiol. 49:1058-1063. http://dx.doi.org/10.1128/JCM.01904-10.
60. White PL, Perry MD, Moody A, Follett SA, Morgan G, Barnes RA. 2011. Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 49:2169-2174. http://dx.doi.org/10.1128/JCM.00101-11.
61. Deeks JJ, Altman DG. 2004. Diagnostic tests 4: likelihood ratios. BMJ 329:168-169. http://dx.doi.org/10.1136/bmj.329.7458.168.
62. Yamakami Y, Hashimoto A, Tokimatsu I, Nasu M. 1996. PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis. J. Clin. Microbiol. 34:2464-2468.
63. Pfeiffer CD, Fine JP, Safdar N. 2006. Diagnosis of invasive aspergillosis using a galactomannan assay: A meta-analysis. Clin. Infect. Dis. 42:1417-1427. http://dx.doi.org/10.1086/503427.
64. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME. 2011. Beta-D-glucan assay for the diagnosis of invasive fungal infections: A meta-analysis. Clin. Infect. Dis. 52:750-770. http://dx.doi.org/10.1093/cid/ciq206.
65. Tsitsikas DA, Morin A, Araf S, Murtagh B, Johnson G, Vinnicombe S, Ellis S, Suaris T, Wilks M, Doffman S, Agrawal SG. 2012. Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis. Med. Mycol. 50:538-542. http://dx.doi.org/10.3109/13693786.2011.630040.
66. Blennow O, Mattsson J. 2011. Standardization of Aspergillus PCR is needed. Bone Marrow Transplant. 46:1018. http://dx.doi.org/10.1038/bmt.2010.220.
67. Loeffler J, Kloepfer K, Hebart H, Najvar L, Graybill JR, Kirkpatrick WR, Patterson TF, Dietz K, Bialek R, Einsele H. 2002. Polymerase chain reaction detection of Aspergillus DNA in experimental models of invasive aspergillosis. J. Infect. Dis. 185:1203-1206. http://dx.doi.org/10.1086/339824.
68. Mennink-Kersten MA, Ruegebrink D, Wasei N, Melchers WJ, Verweij PE. 2006. In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 44:1711-1718. http://dx.doi.org/10.1128/JCM.44.5.1711-1718.2006.
69. Simoneau E, Kelly M, Labbe AC, Roy J, Laverdiere M. 2005. What is the clinical significance of positive blood cultures with Aspergillus sp. in hematopoietic stem cell transplant recipients? A 23 year experience. Bone Marrow Transplant. 35:303-306. http://dx.doi.org/10.1038/sj.bmt.1704793.
70. Sun W, Wang K, Gao W, Su X, Qian Q, Lu X, Song Y, Guo Y, Shi Y. 2011. Evaluation of PCR on bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis: A bivariate metaanalysis and systematic review. PLoS One 6(12):e28467. http://dx.doi.org/10.1371/journal.pone.0028467.